Aligning incentives

In the most comprehensively represented meeting of stakeholders yet convened on the topic, the Global Biological Standards Institute (GBSI) brought together vendors, researchers, journals and funders to hammer out the fundamentals of a three-part plan to solve one of the biggest problems contributing to the "reproducibility crisis" in preclinical research: poor quality and improper use of antibodies.

GBSI President Leonard Freedman told BioCentury the meeting focused on creating guidelines for testing antibody specificity, a process for producer certification and user proficiency training...